FDA DEVICE FACTS
SMARTVERTIGO™ Vestibular Assessment System
VertigoDx, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The SmartVertigo™ Vestibular Assessment System is indicated for use in the medical office, hospital, and healthcare settings for viewing and recording eye movements in patients with symptoms of dizziness caused by peripheral vestibular disorders who are under the supervision of a clinician. The device records abnormal eye movements with an iPhone camera in response to standard positional maneuvers. The device records, tracks, stores, and displays normal and abnormal eye movements, including vertical, horizontal, and torsional. This device provides no diagnosis and does not provide diagnostic recommendations. The target population is individuals 12 years of age and older.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。